Focus RXS (Deseret Biologicals, Inc.)


Welcome to the PulseAid listing for the Focus RXS drug offered from Deseret Biologicals, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Deseret Biologicals, Inc.
NON-PROPRIETARY NAME: Alpha-Ketoglutaricum Acidum, ATP (Adenosine Triphosphate Disodium), Formicum Acidum, Malic Acid, Sarcolacticum Acidum, Dulcamara, Hyoscyamus Niger, Phosphorus, Sabina, Acetylcholine Chloride, Adrenali
SUBSTANCE NAME: .ALPHA.-KETOGLUTARIC ACID; ADENOSINE TRIPHOSPHATE DISODIUM; FORMIC ACID; MALIC ACID; LACTIC ACID, L-; SOLANUM DULCAMARA TOP; HYOSCYAMUS NIGER; PHOSPHORUS; JUNIPERUS SABINA LEAFY TWIG; ACETYLCHOLINE CH
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2014-04-03
END MARKETING DATE: 2020-12-08


Focus RXS HUMAN OTC DRUG Details:

Item DescriptionFocus RXS from Deseret Biologicals, Inc.
LABELER NAME: Deseret Biologicals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 8; 8; 8; 8; 8; 8; 8; 8; 30; 30; 30; 30; 30; 30; 30([hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [h)
START MARKETING DATE: 2014-04-03
END MARKETING DATE: 2020-12-08
PRODUCT ID: 43742-0414_cf66f2b7-2338-477f-888b-dae5fdb7c55f
PRODUCT NDC: 43742-0414
APPLICATION NUMBER:

Other .ALPHA.-KETOGLUTARIC ACID; ADENOSINE TRIPHOSPHATE DISODIUM; FORMIC ACID; MALIC ACID; LACTIC ACID, L-; SOLANUM DULCAMARA TOP; HYOSCYAMUS NIGER; PHOSPHORUS; JUNIPERUS SABINA LEAFY TWIG; ACETYLCHOLINE CH Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Deseret Biologicals, Inc.Focus RXS